In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...
Loop Capital raised the firm’s price target on AppLovin (APP) to $650 from $450 and keeps a Buy rating on the shares. The stock price ...
KeyBanc analyst Jeffrey Hammond raised the firm’s price target on EnPro (NPO) to $230 from $220 and keeps an Overweight rating on the shares.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback